Vote Scores

Home / Companies / ASKA Pharmaceutical Holdings Co., Ltd. / 24 Jun 2025

Meeting · year to 30 June 202520 filers reporting

ASKA Pharmaceutical Holdings Co., Ltd.: meeting of 24 Jun 2025

Votes reported on Form N-PX, item by item

20 Form N-PX filers reported votes at the ASKA Pharmaceutical Holdings Co., Ltd. meeting of 24 Jun 2025. Their records fall into 11 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

9 nominees; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.

234 vote records from 19 filers. 0 of the 19 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management19 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

1 vote records from 1 filers. 1 of the 1 filers that marked the item either way voted against management.

100.0% for0.0% against100.0% against management1 filers100.0% for0.0% against100.0% against management4,653,100 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

12 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management3 filers100.0% for0.0% against0.0% against management9,200 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

26 vote records from 19 filers. 0 of the 19 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management19 filers100.0% for0.0% against0.0% against management803,173 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

76 vote records from 13 filers. 0 of the 13 filers that marked the item either way voted against management.

69.2% for0.0% against30.8% other0.0% against management13 filers61.4% for38.6% against38.6% against management2,994,272 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

18 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management3 filers82.0% for18.0% against18.0% against management209,220 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

3 vote records from 3 filers. No filer marked a management recommendation, so no against-management figure is reported. 3 filers reported this item without a management mark.

0.0% for0.0% against100.0% other3 filers
8

CORPORATE GOVERNANCESecurity holder

Amend Articles to Require Majority Outsider Board

26 vote records from 19 filers. 0 of the 19 filers that marked the item either way voted against management.

0.0% for100.0% against0.0% against management19 filers0.0% for100.0% against0.0% against management803,173 reported shares
9

COMPENSATIONSecurity holder

Approve Restricted Stock Plan

26 vote records from 19 filers. 9 of the 19 filers that marked the item either way voted against management.

47.4% for52.6% against47.4% against management19 filers19.5% for80.5% against19.5% against management803,173 reported shares
10

CAPITAL STRUCTURESecurity holder

Initiate Share Repurchase Program

21 vote records from 15 filers. 0 of the 15 filers that marked the item either way voted against management.

0.0% for100.0% against0.0% against management15 filers0.0% for100.0% against0.0% against management788,073 reported shares
11

CAPITAL STRUCTURESecurity holder

Shareholder Proposal: Approve Purchase of Own Shares

5 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

0.0% for100.0% against0.0% against management4 filers0.0% for100.0% against0.0% against management15,100 reported shares

How the largest families voted

Family1. Directors3. Auditor8. Proposal9. Proposal10. Proposal11. Proposal
VanguardForNo reportAgainstAgainstAgainstNo report
BlackRock and iSharesForNo reportAgainstAgainstNo reportAgainst
DimensionalForNo reportAgainstFor *AgainstNo report
State Street and SPDRForNo reportAgainstAgainstAgainstNo report
American CenturyForNo reportAgainstAgainstAgainstNo report
EquitableForNo reportAgainstAgainstAgainstNo report
Charles SchwabForNo reportAgainstAgainstAgainstNo report
John Hancock and ManulifeForForAgainstFor *No reportAgainst
WisdomTreeForNo reportAgainstFor *AgainstNo report
Lincoln FinancialForNo reportAgainstFor *AgainstNo report
VoyaForNo reportAgainstAgainstAgainstNo report
Brighthouse FundsForNo reportAgainstFor *AgainstNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the ASKA Pharmaceutical Holdings Co., Ltd. meeting?

20 Form N-PX filers reported votes at the meeting of 24 Jun 2025. On say-on-pay, 1 of 1 voted against management (100.0%). 4 proposals from security holders could be told apart in the filings. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by ASKA Pharmaceutical Holdings Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for ASKA Pharmaceutical Holdings Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing ASKA Pharmaceutical Holdings Co., Ltd. with a meeting date within three days of 24 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.